Orientation of mental retardation from neurometabolic diseases;Orientación del retraso mental desde las enfermedades neurometabólicas

Revista de Neurologia

Volumn 43, Issue SUPPL. 1, 2006, Pages

  García Cazorla, Ángels ^a   Perez Duenas B ^a   Pineda, M ^a   Artuch, R ^a   Vilaseca, M A ^a   Campistol, J ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Genetic diagnosis; Mental retardation; Metabolic screening; Neurometabolic diseases

Indexed keywords

4 HYDROXYBUTYRIC ACID; ADENYLOSUCCINATE LYASE; CREATINE;

ACIDURIA; AUTISM; CEREBELLUM DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; CONGENITAL DISORDER; ENZYME DEFICIENCY; EPILEPSY; FAMILY COUNSELING; GENETIC ANALYSIS; HOMOCYSTINURIA; HUMAN; LANGUAGE; MENTAL DEFICIENCY; MENTAL DISEASE; METABOLIC DISORDER; PROTEIN GLYCOSYLATION; SANFILIPPO SYNDROME; TERATOLOGY; UREA CYCLE;

EID: 35348847970     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.43s01.2006420     Document Type: Conference Paper

References (31)

1. Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology 2003; 60: 367-80.
2. Van Karnebeek CD, Jansweijer MC, Leenders AG, Offringa M, Hennekam RC. Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet 2005; 13: 6-25.
3. Moeschler JB, Shevell M. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics 2006; 117: 2304-16.
4. Consden R, Gordon AH, Martin AJP. Qualitative analysus of proteins: a partition chromatographic method using paper. Biochem J 1944; 38: 224-32.
5. Van Karnebeek CD, Scheper FY, Abeling NG, Alders M, Barth PG, Hoovers JM, et al. Etiology of mental retardation in children referred to a tertiary care center: a prospective study. Am J Ment Retard 2005; 110: 253-67.
6. Van Buggenhout GJ, Trijbels JM, Wevers R, Trommelen JC, Hamel BC, Brunner HG, et al. Metabolic studies in older mentally retarded patients: significance of metabolic testing and correlation with the clinical pehnotype. Genet Couns 2001; 12: 1-21.
7. Ryan R, Sunada K. Medical evaluation of persons with mental retardation referred for psychiatric assessment. Gen Hosp Psychiatry 1997; 19: 274-80.
8. Zhang C, Xu K, Dave UP, Wang Y, Matsumoto I. Inborn errors of metabolism discovered in Asian department of pediatrics and mental retardation research center. J Chromatography 2000; 746: 41-9.
9. Wakutani Y, Nakayasu H, Takeshima T, Mori N, Kobayashi K, Endo F, et al. A case of late-onset carbamoyl phosphate synthetase I deficiency, presenting periodic psychotic episodes coinciding with menstrual periods. Rinsho Shinkeigaku 2001; 41: 780-5.
10. Von Wendt L, Simila S, Ruokonen A, Puukka M. Argininosuccinic aciduria in a Finnish woman presenting with psychosis and mental retardation. Ann Clin Res 1982; 14: 145-7.
11. Nassogne MC, Heron B, Touati G, Rabier D, Saudubray JM. Urea cycle defects: management and outcome. J Inherit Metab Dis 2005; 28: 407-14.
12. Gropman AL, Batshaw ML. Cognitive outcome in urea cycle disorders. Mol Genet Metab 2004; 81 (Suppl 1): S58-62.
13. Muñoz MD, Monfort P, Gaztelu JM, Felipo V. Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro. Neurochem Res 2000; 25: 437-41.
14. Salomons GS, Van Dooren SJ, Verhoeven NM, Cecil KM, Ball WS, Degrauw TJ, et al. X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency síndrome. Am J Hum Genet 2001; 68: 1497-500.
15. Rosenberg EH, Almeida LS, Kleefstra T, DeGrauw RS, Yntema HG, Bahi N, et al. High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet 2004; 75: 97-105.
16. Salomons GS, Van Dooren SJ, Verhoeven NM, Marsden D, Schwartz C, Cecil KM, et al. X-linked creatine transporter defect: an overview. J Inherit Metab Dis 2003; 26: 309-18.
17. Poo-Argüelles P, Arias A, Vilaseca MA, Ribes A, Artuch R, Sans-Fitó A, et al. X-Linked creatine transporter deficiency in two patients with severe mental retardation and autism. J Inherit Metab Dis 2006; 29: 220-3.
18. Verhoeven NM, Salomons GS, Jakobs C. Laboratory diagnosis of defects of creatine biosynthesis and transport. Clin Chim Acta 2005; 361: 1-9.
19. Gordon N. Succinic semialdehyde dehydrogenase deficiency (SSADH) (4-hydroxybutyric aciduria, gamma-hydroxybutyric aciduria). Eur J Pediatr Neurol 2004; 8: 261-5.
20. Jakobs C, Jaeken J, Gibson KM. Inherited disorders of GABA metabolism. J Inher Metab Dis 1993; 16: 704-15.
21. Gibson KM, Pearl PL. Significant behavioural disturbance in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria). Biol Psychiatry 2003; 54: 763-8.
22. Gabrielli O, Coppqa GV, Bruni S, Villani GR, Pontarelli G, DiNatale P. An adult Sanfilippo type A patient with homozygous mutation R206P in the sulfamidase gene. Am J Med Genet 2005; 133: 85-9.
23. Barone R, Nigro F, Triulzi F, Musumeci S, Fiumara A, Pavone L. Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome). Neuropediatrics 1999; 30: 270-4.
24. Krivit W. Allogenic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Springer Semin Immunopathol 2004; 26: 119-32.
25. Köhler M, Assmann B, Bräutigam C, Storm W, Marie S. Adenylosuccinase deficiency: possibly underdiagnosed encephalopathy with variable clinical features. Eur J Pediatr Neurol 1999; 3: 3-6.
26. Van den Berghe G, Vincent MF, Jaeken J. Inborn errors of the purine nucleotide cycle: adenylosuccinase deficiency. J Inherit Metab Dis 1997; 20: 193-202.
27. Van den Berghe F, Bosschart AN, Hageman G, Duran M, Poll-The BT. Adenylosuccinase deficiency with neonatal onset, severe epileptic seizures and sudden death. Neuropediatrics 1998; 29: 51-3.
28. Holder-Espinasse M, Marie S, Bourrouillou G, Ceballos-Picot I, Nassogne MC, Faivre L, et al. Towards a suggestive facial dysmorphism in adenylosuccinate lyase deficiency? J Med Genet 2002; 39: 440-2.
29. Nassogne MC, Henrot B, Aubert G, Bonnier C, Marie S. Adenylosuccinate deficiency and unusual cause of early-onset epilepsy associated with acquired microcephaly. Brain Dev 2000; 22: 383-6.
30. Assman B, Hacker R, Peters V, Schaefer JR, Arndt T, Mayatepek E, et al. A new subtype of a congenital disorder of glycosylation (CDG) with mild clinical manifestations. Neuropediatrics 2001; 32: 313-8.
31. Fonteh A, Harrington R, Humer A, Biringer R, Riggins J, Harrington M. Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods. Dis Markers 2006; 22: 39-46.